Contact us
Privacy Policy
Terms & Conditions
Email Whitelisting
Staying Healthy
GLP-1s fail to slow progression of Alzheimer’s: Novo Nordisk
0
Share:
The trials showed an effect on Alzheimer’s biomarkers, though Novo did not specify which ones.
Share:
More Stories
Staying Healthy
Cassidy: ‘There is a deal that could be made’ on ACA subsidies by end of year
Staying Healthy
Federal judge strikes Biden-era ban on transgender care discrimination
Generated by
Feedzy
